Abeona Therapeutics (ABEO) Non Operating Interest Expenses (2015 - 2018)
Abeona Therapeutics (ABEO) posted quarterly Non Operating Interest Expenses of $2000.0 for Q4 2018, up 100.0% year-over-year from $1000.0 in Q4 2017, and down 33.33% quarter-over-quarter from $3000.0 in Q3 2018.
Abeona Therapeutics (ABEO) Non Operating Interest Expenses (2015 - 2018) Analysis & Trends
Abeona Therapeutics' Non Operating Interest Expenses history runs 4 years deep, the most recent figure standing at $2000.0 for Q4 2018.
- In Q4 2018, Non Operating Interest Expenses rose 100.0% year-over-year to $2000.0; the TTM figure through Jun 2019 stood at $5000.0 (down 44.44% YoY), while the FY2018 annual figure was $11000.0, up 37.5% from the prior year.
- Non Operating Interest Expenses for Q4 2018 stood at $2000.0, down from $3000.0 in the prior quarter.
- The five-year high for Non Operating Interest Expenses was $3000.0 in Q2 2017, with the low at $1000.0 in Q3 2015.
- The 4-year median for Non Operating Interest Expenses is $2000.0 (2015), against an average of $2000.0.
- The sharpest annual moves came in 2016 and 2017: Non Operating Interest Expenses plunged 50.0% in 2016, then jumped 200.0% in 2017.
- Abeona Therapeutics' Non Operating Interest Expenses stood at $2000.0 in 2015, then changed by 0.0% to $2000.0 in 2016, then slumped by 50.0% to $1000.0 in 2017, then surged by 100.0% to $2000.0 in 2018.
- Business Quant data shows ABEO's Non Operating Interest Expenses at $2000.0 in Q4 2018, $3000.0 in Q3 2018, and $3000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Sep 30, 2017 | 2,000.00 |
| Jun 30, 2017 | 3,000.00 |
| Mar 31, 2017 | 2,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Mar 31, 2016 | 2,000.00 |
| Dec 31, 2015 | 2,000.00 |
| Sep 30, 2015 | 1,000.00 |
| Jun 30, 2015 | 2,000.00 |